Dexcom Stelo over-the-counter glucose monitor cleared by the FDA
source link: https://www.cnbc.com/2024/03/05/dexcom-announces-stelo-has-been-cleared-by-the-fda-.html
Go to the source link to view the article. You can view the picture content, updated content and better typesetting reading experience. If the link is broken, please click the button below to view the snapshot at that time.
Dexcom’s first-ever over-the-counter glucose monitor patch gets FDA clearance
In this article
Dexcom on Tuesday announced that its new over-the-counter continuous glucose monitor named Stelo has been cleared for use by the U.S. Food and Drug Administration, and it will be available for purchase online this summer.
Continuous glucose monitors, or CGMs, are small sensors that poke through the skin to track glucose levels in real-time. They are primarily used by patients with diabetes. Information is wirelessly sent to a smartphone, and can help alert users, their families, and their doctors to emergencies.
Dexcom’s new CGM is designed for patients with Type 2 diabetes who do not use insulin, and it is the first glucose biosensor that does not require a prescription. This means Stelo will be accessible to people who do not have insurance coverage for CGMs, Dexcom said.
There are more than 25 million Type 2 diabetes patients in the U.S. that do not use insulin, according to the release from Dexcom. While Dexcom’s existing G7 CGM system is available to this population, patients have to get a prescription for it. As a result, it’s not easily accessible to all Type 2 patients.
“CGMs can be a powerful tool to help monitor blood glucose. Today’s clearance expands access to these devices by allowing individuals to purchase a CGM without the involvement of a health care provider,” Dr. Jeff Shuren, director of the FDA’s Center for Devices and Radiological Health, said in a release.
Shares of Dexcom popped more than 2% in extended trading Tuesday.
Dexcom shared Stelo’s name, and that the device had been submitted to the FDA for review in February. The sensor will be worn on the upper arm and lasts for up to 15 days before it needs to be replaced, according Dexcom.
Jake Leach, chief operating officer at Dexcom, told CNBC in February that Stelo will have a unique platform and branding. The platform will be tailored to the needs of these Type 2 patients, he said, which means it will not include many of the alerts and notifications meant for diabetes patients at risk of experiencing more serious emergencies.
“It’s designed to be a simpler experience,” Leach said in an interview. “There’s a lot of people who could benefit.”
Leach said as Dexcom can demonstrate the benefits of Stelo, the company believes insurance companies will eventually pay for it. He said Dexcom decided to get the product out to the market at an “approachable” cash pay price first to help get it into users’ hands quickly.
“I think it’s important for people to have that insight — it’s like a mirror into their body,” he said. “It’s very personal.“
Don’t miss these stories from CNBC PRO:
Recommend
-
10
After decades of requiring diabetes patients to perform routine fingersticks throughout the day or be implanted with a sensor—or both—to keep track of their blood glucose levels, the current holy grail of medtech is the creation of a complete...
-
4
Dexcom G6 app crashing/not working on AW series 7 sodaftl
-
5
The Apple Watch Has Been Cleared by the FDA to Monitor Parkinson’s Disease Symptoms Approximately 60,000 new cases are diagnosed yearly.
-
4
How To Use Your Apple Watch As A Glucose Monitor
-
6
Inside the secret mission to add glucose monitor to Apple Watch
-
4
Dexcom stock slumps on news of Apple’s work on noninvasive bl...
-
5
Apple hits major milestones in creating noninvasive blood glucose monitor Wednesday, February 22, 2023 1:56 pm
-
4
Dexcom stock slumps on news of Apple’s work on noninvasive blood glucose monitor Wednesday, February 22, 2023 5:17 pm
-
2
TechHow Dexcom and Abbott are moving beyond diabetes with blood sugar monitoring
-
2
Dexcom’s new continuous glucose monitor is a health tech gadget with purpose / The Stelo CGM is meant to give Type 2 diabetics who don’t need insulin a more affordable way to monitor their blood sugar.
About Joyk
Aggregate valuable and interesting links.
Joyk means Joy of geeK